Small Molecule mRNA Biology Modulators

Anima Biotech is transforming target and drug discovery with a unique Visual Biology approach, with pipeline of small molecule mRNA biology modulators, addressing hard-to-drug areas traditional approaches can't reach:

• Immunology: Lung fibrosis candidate advancing in preclinical stage.
• Oncology: Solid tumor lead compounds entering preclinical stage, with additional programs targeting Lymphoma and Neuroblastoma.
• Neuroscience: Alzheimer's disease and Pain management.

With 20+ programs advancing across our internal pipeline and partnerships with AbbVie, Takeda, and Lilly, we are actively exploring new collaborations. Let’s partner: [email protected]